MIDDLE EAST RESPIRATORY SYNDROME CoV: AN EVOLVING VIRAL THREAT TO HUMAN HEALTH
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2015, Vol 6, Issue 12
Abstract
The Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease. It is caused by a novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Specific drug treatment exists for MERS and infection prevention and control measures are crucial to prevent spread in health-care facilities.The outbreak of Severe Acute Respiratory Syndrome (SARS) in 2003, led to 8,422 cases and 916 deaths worldwide which highlighted the potential for newly emerging zoonotic coronaviruses to transmit from person one to another, especially in healthcare settings, and to cause severe human illness.MERS-CoV is a novel virus among the genus Betacoronavirus, which was initially identified in Saudi Arabia in September 2012, in two patients with severe pneumonia Upto 7 May 2013, the cases in France were identified, 30 cases had been confirmed as infected by the coronavirus worldwide which included four diagnosed in the United Kingdom (UK) and two in Germany. Two cases of severe respiratory infection have been confirmed as caused by a novel coronavirus. The case guideline has been issued by the World Health Organization (WHO) which is mainly based on acute respiratory illness, pneumonia and travel history. The incubation time is crucial as it is playing a major role in suspecting Saudi Arabia and Qatar, and define its clinical features. The presumed length of the incubation period was compared with known incubation periods of human coronavirus infections including that of severe acute respiratory syndrome (SARS).Our main aim of the article is to give overview on the MERS CoV disease pointing out its symptoms, diagnosis, spread, therapy and cases reported up to now. This is a uncommon virus and details about MERS is still unknown as it is often confused as some common viral respiratory disease so we have tried to collect the possible data and reports in our content.
Authors and Affiliations
Nikita Saraswat, Mohammad Faizan , Rituparna Palit, Pranay Wal
Keywords
Related Articles
- EP ID EP112017
- DOI 10.7897/2230-8407.0612152
- Views 127
- Downloads 0
PREVALENCE OF HYPERTENSION AMONG POPULATION OF SULTANPUR KUNHARI AND ITS SURROUNDING AREA, HARIDWAR, UTTARAKHAND, INDIA
The average prevalence of hypertension in India is 25% in urban and 10% in rural inhabitants. Prevalence of hypertension has been found to increase in traditional populations undergoing innovation. There is a strong corr...
THE INDIAN PHARMACEUTICAL INDUSTRY; EVOLUTION OF REGULATORY SYSTEM AND PRESENT SCENARIO
Indian pharmaceutical industry evolved in true sense only after independence. Government provided the impetus to growth with the establishment of few public sector units. Healthcare facilities in India are still below st...
DOCUMENTATION OF TRADITIONAL KNOWLEDGE ABOUT USES OF MEDICINAL PLANTS FOUND IN KIRTHAR NATIONAL PARK, DISTRICT DADU, SINDH, PAKISTAN
National Parks are diverse habitats for different medicinal plant species. Keeping the diversity and variation in view twenty one different areas in Pakistan have been declared as National Parks. Kirthar National Park is...
GREEN SYNTHESIS OF GOLD NANOPARTICLES USING TOONA CILIATA METHANOL BARK EXTRACT AND THEIR CHARACTERISATION
In the present study, we identified and justified the use of MeOH extract from Toona ciliata bark as a reducing and capping agent for the ecofriendly synthesis of gold nanoparticles on the basis of modern analytical tech...
ANTIMICROBIAL ACTIVITY OF FICUS RACEMOSA L. AND CISSAMPELOS PAREIRA L. VAR. HIRSUTA (DC) FORMAN., AGAINST E. COLI, P. AEROGINOSA, S. AUREUS AND B. SUBTILIS
The present work was designed to assess the antimicrobial activity of the methanolic extracts of the bark of Ficus racemosa L. and root of Cisampelos pareira L. var. hirsuta (DC) Forman. The antimicrobial activity of the...